Completed OBSERVATIONAL NCT02078297

IL-17 Role in Variants of Psoriasis

Role of Il-17a in Difficult to Treat Variants of Psoriasis Including Palmo-plantar Psoriasis

Sponsor: Innovaderm Research Inc.

Conditions Elbow Psoriasis Lower Leg Psoriasis Non-pustular Palmo-plantar Psoriasis Pustular Palmo-plantar Psoriasis Scalp Psoriasis

Updated 10 times since 2017 Last updated: Mar 25, 2015 Started: Feb 28, 2014 Primary completion: Feb 28, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02078297, this observational or N/A phase trial focuses on Elbow Psoriasis and Lower Leg Psoriasis and remains completed. Sponsored by Innovaderm Research Inc., it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innovaderm Research Inc.

Data source: Innovaderm Research Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada